News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Innovus Pharma Selects Lebanese-Canadian Hospital for Its Post-Marketing Clinical Trials for CIRCUMserum™ and EjectDelay™


11/11/2013 12:02:07 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LA JOLLA, Calif., Nov. 11, 2013 (GLOBE NEWSWIRE) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company") www.innovuspharma.com (OTCBB:INNV) today announced that the Company selected the Lebanese-Canadian Hospital in Beirut, Lebanon for its two post-marketing trials for CIRCUMserum™ to alleviate reduced penile sensitivity and EjectDelay™ for premature ejaculation.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES